Year: 2024

Walrus Pump Announces Financial and Operating Results for Three Quarters of FY2024

Written by Customer Service on December 17, 2024. Posted in Earnings Releases And Operating Results.

Steady Dual Growth in Domestic and International Sales: Walrus Pump Driving Industry Supply Chain Upgrades TAIPEI, Taiwan, Dec. 17, 2024 (GLOBE NEWSWIRE) — The leading pump brand Walrus Pump (TPEX: 6982) recently hosted its pre-listing performance presentation in November. The company offers a wide range of pump solutions, catering to needs from household water supply and agricultural irrigation to advanced industrial processes. Its core products serve both daily life and industrial applications, not only meeting consumer needs but also supporting high-tech uses such as data centers and fast charging station cooling. Through technological innovation and strategic market positioning, Walrus Pump has firmly established itself as the leader in Taiwan’s water pump market. For the first three quarters of FY2024, the company recorded...

Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd

Written by Customer Service on December 17, 2024. Posted in Mergers And Acquisitions.

WESTPORT, Conn., Dec. 17, 2024 (GLOBE NEWSWIRE) — Portage Biotech, Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of novel multi-targeted therapies for use as monotherapy and in combination, is pleased to announce that it has entered into a Letter of Intent (“LOI”) with Immunova, LLC, (“Immunova”) a private Connecticut-based biotechnology company. Under the terms of the LOI, Portage and Immunova have agreed to negotiate a definitive option agreement for Immunova or an affiliate to acquire the entire share capital of iOx Therapeutics, Ltd (“iOx”), a wholly owned subsidiary of Portage. iOx is focused on developing liposomal iNKT agonists, and its lead candidate, PORT-2, has demonstrated promising preliminary clinical activity. Alex Pickett, CEO of Portage Biotech, commented:...

CTO Realty Growth Expands Presence In Tampa Metro Area with Acquisition of Grocery Anchored Property

Written by Customer Service on December 17, 2024. Posted in Mergers And Acquisitions.

WINTER PARK, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) an owner and operator of high-quality, open-air shopping centers located in the higher growth Southeast and Southwest markets of the United States (the “Company”), today announced the addition of its second grocery anchored property in the Tampa, Florida market with the acquisition of Granada Plaza for $16.8 million, prior to closing costs and adjustments. Granada Plaza is a 74,000 square-foot shopping center, anchored by a high-performing Publix, and located in the city of Dunedin, Florida, a densely populated and growing retail market in the Tampa metro area. The property is situated on seven acres and is 95% occupied. “This acquisition adds another grocery anchored shopping center to our portfolio and further expands our presence in...

DAVIDsTEA Reports Improved Financial Results for Third Quarter of Fiscal 2024

Written by Customer Service on December 17, 2024. Posted in Earnings Releases And Operating Results.

Strong sales momentum combined with improved financial performance and operational efficienciesSales of $14.0 million, an increase of 15.6% over the prior year Gross profit margin of 51.5%, significantly better compared to 37.9% in prior year Net loss of $1.6 million, an improvement from a loss of $3.7 million in prior year Adjusted EBITDA1 of $0.8 million versus negative $2.5 million in prior year Two flagship store openings in Montreal: Royalmount and Eaton CentreMONTREAL, Dec. 17, 2024 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (TSX-Venture: DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North America, announced today its financial results for the third quarter ended November 2, 2024. “We are highly encouraged by our ongoing sales momentum in the third quarter of 2024 with double-digit growth across all distribution...

PhenixFIN Corporation Announces Fiscal Year and Fourth Quarter 2024 Financial Results

Written by Customer Service on December 17, 2024. Posted in Earnings Releases And Operating Results.

For the Fiscal Year ended 2024 NAV per share grew 12% year over year NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) — PhenixFIN Corporation (NASDAQ: PFX, PFXNZ) (the “Company”), a publicly traded business development company, today announced its financial results for the fiscal fourth quarter of 2024. HighlightsFourth quarter total investment income of $5.6 million; net investment income of $0.5 million Net asset value (NAV) of $160.3 million, or $79.37 per share as of September 30, 2024, vs. $70.75 per share as of September 30, 2023 Weighted average yield was 12.3% on debt and other income producing investments as of the fiscal year end On October 1, 2024 the Company completed the acquisition of approximately 80% of the equity of The National Security Group, Inc. (“NSG”) an Alabama based insurance holding company.David...

Americold Realty Trust, Inc. Declares Fourth Quarter 2024 Dividend

Written by Customer Service on December 17, 2024. Posted in Dividend Reports And Estimates.

ATLANTA, GA., Dec. 17, 2024 (GLOBE NEWSWIRE) — Americold Realty Trust (NYSE: COLD), a global leader in temperature-controlled logistics, real estate, and value-added services focused on the ownership, operation, acquisition and development of temperature-controlled warehouses, today announced that its Board of Directors has declared a dividend of $0.22 per share for the fourth quarter of 2024, payable to holders of the Company’s common stock. The dividend will be payable in cash on January 15, 2025 to stockholders of record at the close of business on December 31, 2024. About Americold Realty Trust, Inc. Americold is a global leader in temperature-controlled logistics real estate and value-added services. Focused on the ownership, operation, acquisition, and development of temperature-controlled warehouses, Americold owns and/or...

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

Written by Customer Service on December 17, 2024. Posted in Public Companies.

Teva hosting investor call today at 8:00 a.m. ET (U.S.)Primary endpoints met in ulcerative colitis (UC) and Crohn’s disease (CD), the most common forms of inflammatory bowel disease (IBD) Primary endpoint results in UC and CD for high dose represent the highest achieved with any TL1A monoclonal antibody Sanofi and Teva plan to initiate Phase 3 development in IBD, pending regulatory discussionsPARSIPPANY, N.J. and PARIS, Dec. 17, 2024 (GLOBE NEWSWIRE) — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Sanofi today announce that the Phase 2b RELIEVE UCCD study met its primary endpoints in patients with ulcerative colitis (UC) and Crohn’s disease (CD). RELIEVE UCCD investigated duvakitug (TEV’574/SAR447189), a human IgG1-λ2 monoclonal antibody targeting TL1A, for the treatment...

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease

Written by Customer Service on December 17, 2024. Posted in Public Companies.

Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s diseasePrimary endpoints met in ulcerative colitis (UC) and Crohn’s disease (CD), the most common forms of inflammatory bowel disease (IBD) Primary endpoint results in UC and CD for high dose represent the highest achieved with any TL1A monoclonal antibody Sanofi and Teva plan to initiate phase 3 development in IBD, pending regulatory discussions Program underscores Sanofi’s Immunology leadership ambitionParis and Parsippany, NJ, December 17, 2024. Sanofi and Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd., today announced that the RELIEVE UCCD phase 2b study met its primary endpoints in patients with ulcerative colitis (UC) and Crohn’s disease (CD). RELIEVE UCCD assessed duvakitug, a human IgG1-λ2...

MINILUXE ANNOUNCES FRANCHISEE OPERATOR PARTNERSHIP

Written by Customer Service on December 17, 2024. Posted in Public Companies.

MiniLuxe signs agreement with respected Boston entrepreneur, Quynh Pham, who will also invest in MiniLuxe’s private placement and advise the Company on its talent recruitment. Boston, MA, Dec. 17, 2024 (GLOBE NEWSWIRE) — MiniLuxe Holding Corp. (TSXV: MNLX) (“MiniLuxe” or the “Company”) is pleased to announce its inaugural franchisee operator partner, Ms. Quynh Pham, a Boston-based serial retail entrepreneur and business leader. Ms. Pham will also be investing in the company’s upcoming private placement and play a role in advising the Company on the recruitment, development and retention of nail designer talent. Ms. Pham immediately begins her franchising journey with a MiniLuxe location in Brookline, Massachusetts, which is opening this week. Furthermore, over the next three years, she will invest up to $USD 2M to open three or...

REE Automotive Reports Q3 2024 Results: Reservations Surge by 230% as Production Begins and Liquidity Increases, Reaffirming BoM Breakeven Target for H2 2025

Written by Customer Service on December 17, 2024. Posted in Earnings Releases And Operating Results.

REE Automotive Q3 2024 EarningsCompany will host an earnings call on December 17, 2024 at 8:30 a.m. ET.Demand for Powered by REE vehicles surges as reservations grow by 230% to $137 million* including reservations for production that extend beyond 2025. Significant progress toward integration of REEs software defined vehicle technology (SDV) into leading OEMs in several vehicle categories. Production of flagship P7 medium duty electric truck kicked-off according to plan targeting first deliveries in H1 2025 supported by strategic partner Motherson and Detroit-based Roush Industries. Production ramp up is targeted for H2 2025 reaffirming Company’s target to reach bill-of-materials (BoM) breakeven in H2 2025 in the low hundreds of vehicles. REE’s Autonomous-ready X by-wire architecture continues to generate strong interest for...

Year: 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals